Prosecution Insights
Last updated: October 02, 2026
Application No. 18/280,201

THERMOPLASTIC ELASTOMER COMPOSITION

Final Rejection §103
Filed
Sep 01, 2023
Priority
Mar 05, 2021 — JP 2021-035465 +1 more
Examiner
NERANGIS, VICKEY M
Art Unit
1763
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Mitsui Chemicals Inc.
OA Round
2 (Final)
57%
Grant Probability
Moderate
3-4
OA Rounds
1m
Est. Remaining
86%
With Interview

Examiner Intelligence

Grants 57% of resolved cases
57%
Career Allowance Rate
669 granted / 1183 resolved
-8.4% vs TC avg
Strong +29% interview lift
Without
With
+29.0%
Interview Lift
resolved cases with interview
Typical timeline
3y 2m
Avg Prosecution
42 currently pending
Career history
1234
Total Applications
across all art units

Statute-Specific Performance

§101
0.6%
-39.4% vs TC avg
§103
49.7%
+9.7% vs TC avg
§102
15.1%
-24.9% vs TC avg
§112
23.3%
-16.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1183 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Response to Amendment All outstanding rejections, except for those maintained below, are withdrawn in light of applicant’s amendment filed on 8/20/2026. The text of those sections of Title 35, U.S. Code not included in this action can be found in a prior office action. No new grounds of rejection are set forth below. Thus, the following action is properly made final. Claim Rejections - 35 USC § 103 Claims 1-7 are rejected under 35 U.S.C. 103 as being unpatentable over Kamiya (JP 2015-160886, machine translation cited on IDS dated 11/13/2023). The rejection is adequately set forth in paragraph 3 of Office action mailed 4/20/2026 and is incorporated here by reference. Response to Arguments Applicant's arguments filed 8/20/2026 have been fully considered but they are not persuasive. Specifically, applicant argues that Kamiya’s ethylene-α-olefin copolymer having kinematic viscosity at 100°C and 40°C of 300-5000 mm2/s and 4000-100,000 mm2/s, respectively, does not read on the claimed kinematic viscosity at 100°C and 40°C. It is the examiner’s position that the endpoints disclosed by Kimiya of 300 and 4,000 mm2/mm, respectively, share an endpoint with the claimed ranges 30-300 mm2/g and 300-4,000 mm2/g, respectively. It is well settled that where the prior art describes the components of a claimed compound or compositions in concentrations within or overlapping the claimed concentrations a prima facie case of obviousness is established. See In re Harris, 409 F.3d 1339, 1343, 74 USPQ2d 1951, 1953 (Fed. Cir 2005); In re Peterson, 315 F.3d 1325, 1329, 65 USPQ 2d 1379, 1382 (Fed. Cir. 1997); In re Woodruff, 919 F.2d 1575, 1578 16 USPQ2d 1934, 1936-37 (CCPA 1990); In re Malagari, 499 F.2d 1297, 1303, 182 USPQ 549, 553 (CCPA 1974). Therefore, it would have been obvious to one of ordinary skill in the art to utilize an ethylene-α-olefin copolymer having claimed kinematic viscosity as a suitable kinematic viscosity. A reference may be relied upon for all that it would have reasonably suggested to one having ordinary skill the art, including nonpreferred embodiments. Merck & Co. v. Biocraft Laboratories, 874 F.2d 804, 10 USPQ2d 1843 (Fed. Cir.), cert. denied, 493 U.S. 975 (1989). Applicant also argues that Kamiya does not disclose a single copolymer having claimed kinematic viscosity properties at 40°C and 100°C. The examiner agrees, however, a reference may be relied upon for all that it would have reasonably suggested to one having ordinary skill the art, including nonpreferred embodiments. Merck & Co. v. Biocraft Laboratories, 874 F.2d 804, 10 USPQ2d 1843 (Fed. Cir.), cert. denied, 493 U.S. 975 (1989). Kamiya discloses a polymer composition comprising 100 parts by weight (pbw) block copolymer; 1-200 pbw ethylene-α-olefin copolymer (b) having kinematic viscosity at 100°C and 40°C of 300-5000 mm2/s and 4000-100,000 mm2/s, respectively, number average molecular weight of 100-30,000 with a narrow Mw/Mn distribution of 1.0-3 (paragraphs 0055-0056) and ethylene content 3-80 mol %; 1-200 pbw ethylene-α-olefin copolymer (c) having kinematic viscosity at 100°C and 40°C of 1-299 mm2/s and 1-3999 mm2/s, respectively, and ethylene content of 30-80 mol % (paragraph 0052); and 0-100 pbw polyolefin having MFR of 0.1-500 g/10 min (abstract; paragraphs 0009, 0039, and 0055). Tables 2 and 3 (in original Japanese-language document) have Examples 8-10 that comprise 100 pbw SEPS (block copolymer styrene block and hydrogenated polyisoprene block) and 100 pbw of a blend of ethylene-α-olefin copolymer (b) and ethylene-α-olefin copolymer (c) having kinematic viscosity at 100°C of 159, 145, and 145 mm2/s, respectively, and kinematic viscosity at 40°C of 1978, 1694, and 1694 mm2/s, respectively (see Tables 4 and 5). This blend also reads on the claimed ethylene/α-olefin copolymer (B) because b-1, b-2, and c-2 are all ethylene/propylene copolymers ( PNG media_image1.png 24 194 media_image1.png Greyscale ). While the individual exemplified polymers do not meet the claimed kinematic viscosities, see Table 1 for values of b-1, b-2, and c-2, the blends do. See paragraph 0126 of the instant specification which teaches that the ethylene/α-olefin copolymer (B) “may be used singly, or two or more of such copolymers.” Applicant argues that that additional experiments discussed in the specification show that kinematic viscosity affects compression set and permanent set. The data is not persuasive for three reasons. First, the data has not been presented in the form of a 132 declaration and therefore cannot be relied upon for establishing patentable subject matter. Second, the data is not a direct comparison to the prior art because Kamiya exemplifies formulations comprising a blend of ethylene-α-olefin copolymers having claimed kinematic viscosity at 100°C and 40°C. Third, the data is not reasonably commensurate in scope with the scope of the claims because the data only shows criticality for kinematic viscosity at 40°C of 400 mm2/s. Case law holds that evidence is insufficient to rebut a prima facie case if not commensurate in scope with the claimed invention. In re Grasselli, 713 F.2d 731, 741, 218 USPQ 769, 777 (Fed. Cir. 1983). Conclusion THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to VICKEY NERANGIS whose telephone number is (571)272-2701. The examiner can normally be reached 8:30 am - 5:00 pm EST, Monday - Friday. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Joseph Del Sole can be reached at (571)272-1130. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /VICKEY NERANGIS/Primary Examiner, Art Unit 1763 vn
Read full office action

Prosecution Timeline

Sep 01, 2023
Application Filed
Apr 20, 2026
Non-Final Rejection mailed — §103
Aug 20, 2026
Response Filed
Sep 23, 2026
Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12742077
SURFACE-TREATED INFRARED-ABSORBING FINE PARTICLES AND METHOD FOR PRODUCING THE SAME, INFRARED-ABSORBING FINE-PARTICLE DISPERSION LIQUID, AND INFRARED-ABSORBING FINE-PARTICLE DISPERSION BODY
3y 5m to grant Granted Sep 22, 2026
Patent 12742065
Polymer and Elastomer Compositions Having Carbon Nanostructure Additives and Articles Formed Therefrom for Use in EMI and RFI Shielding and in Pressure Sensing Seals Having Quantum Tunneling Composite Effects
3y 7m to grant Granted Sep 22, 2026
Patent 12735559
IONOMER RESIN
3y 3m to grant Granted Sep 15, 2026
Patent 12715980
STABILIZER COMPOSITION FOR SILYL-MODIFIED POLYMER SEALANTS
4y 7m to grant Granted Aug 25, 2026
Patent 12715999
AQUEOUS DISPERSION OPACIFYING PIGMENT PARTICLES
3y 10m to grant Granted Aug 25, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
57%
Grant Probability
86%
With Interview (+29.0%)
3y 2m (~1m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 1183 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month